Results 231 to 240 of about 338,989 (310)
Geometric properties of almost pure metric plastic pseudo-Riemannian manifolds. [PDF]
Karaman C, Gezer A, Khan MNI, Ucan S.
europepmc +1 more source
A Python package for fast GPU‐based proton pencil beam dose calculation
Abstract Purpose Open‐source GPU‐based Monte Carlo (MC) proton dose calculation algorithms provide high speed and unparalleled accuracy but can be complex to integrate with new applications and remain slower than GPU‐based pencil beam (PB) methods, which sacrifice some physical accuracy for sub‐second plan calculation.
Mahasweta Bhattacharya+4 more
wiley +1 more source
Monogamy relations for relativistically causal correlations. [PDF]
Weilenmann M.
europepmc +1 more source
Log file‐based quality assurance method for respiratory gating system
Abstract Background As medical linear accelerator technology advances, enabling higher dose rate deliveries, hypofractionation regimens has increased. This necessitates respiratory gating systems that synchronize radiation delivery with tumor position, requiring simple rigorous quality assurance (QA) to ensure treatment accuracy and patient safety ...
Wonjoong Cheon+7 more
wiley +1 more source
Measurement with indefinite causal order and the Sagnac interferometer. [PDF]
Barnett SM, Croke S, Franke-Arnold S.
europepmc +1 more source
Quantum Collapse and Computation in an Everett Multiverse. [PDF]
Tamburini F, Licata I.
europepmc +1 more source
Relationship of cognitive decline with glucocerebrosidase activity and amyloid‐beta 42 in DLB and PD
Abstract Objective Dementia with Lewy bodies (DLB) and Parkinson's disease (PD) share clinical, pathological, and genetic risk factors, including GBA1 and APOEε4 mutations. Biomarkers associated with the pathways of these mutations, such as glucocerebrosidase enzyme (GCase) activity and amyloid‐beta 42 (Aβ42) levels, may hold potential as predictive ...
Maria Camila Gonzalez+15 more
wiley +1 more source
Model-Informed Clinical Pharmacology Profile of a Novel Fixed-Dose Combination of Nivolumab and Relatlimab in Adult and Adolescent Patients with Solid Tumors. [PDF]
Zhao Y+8 more
europepmc +1 more source